Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.

Saved in:
Bibliographic Details
Title: Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.
Authors: Shah TT; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK; Division of Surgery and Interventional Sciences, University College London, London, UK. Electronic address: t.shah@imperial.ac.uk., Kanthabalan A; Division of Surgery and Interventional Sciences, University College London, London, UK., Otieno M; Division of Surgery and Interventional Sciences, University College London, London, UK., Pavlou M; Department of Statistical Science, University College London, London, UK., Omar R; Department of Statistical Science, University College London, London, UK., Adeleke S; Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Oncology, King's College London, London, UK; Department of Oncology, Maidstone and Tunbridge Wells Hospital, Maidstone, UK; School of Cancer & Pharmaceutical Sciences, King's College London, Queen Square, London WC1N 3BG, UK; High Dimensional Neurology, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK., Giganti F; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK., Brew-Graves C; Division of Medicine, Faculty of Medicine, University College London, London, UK., Williams NR; Division of Surgery and Interventional Sciences, University College London, London, UK., Grierson J; Division of Surgery and Interventional Sciences, University College London, London, UK., Miah H; Division of Surgery and Interventional Sciences, University College London, London, UK., Emara A; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK; Urology Department, Ain Shams University Hospitals, Cairo, Egypt., Haroon A; Department of Nuclear Medicine, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK., Latifoltojar A; Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, Royal Marsden NHS Foundation Trust, London, UK., Sidhu H; Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK., Clemente J; Division of Surgery and Interventional Sciences, University College London, London, UK., Freeman A; Department of Histopathology, University College London Hospital NHS Foundation Trust, London, UK., Orczyk C; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK., Nikapota A; Sussex Cancer Centre. Royal Sussex County Hospital, Brighton, UK., Dudderidge T; Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK., Hindley RG; Department of Urology, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK., Virdi J; Department of Urology, The Princess Alexandra Hospital NHS Trust, Harlow, UK., Arya M; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Payne H; Department of Oncology, University College London and University College London Hospital NHS Foundation Trust, London, UK., Mitra A; Department of Oncology, University College London and University College London Hospital NHS Foundation Trust, London, UK., Bomanji J; Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK., Winkler M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Horan G; Department of Oncology, Queen Elizabeth Hospital, Kings Lynn, UK., Moore CM; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK., Emberton M; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospital NHS Foundation Trust, London, UK., Punwani S; Division of Medicine, Faculty of Medicine, University College London, London, UK; Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK., Ahmed HU; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
Source: European urology [Eur Urol] 2022 Jun; Vol. 81 (6), pp. 598-605. Date of Electronic Publication: 2022 Mar 31.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7560
DOI:10.1016/j.eururo.2022.02.022